Blue Horseshoe Stocks: BLDV Review & More

Blue Diamond Ventures, Inc. BLDV

One among the many great calls to come out of our daily live trader’s chats* recently, BLDV came into view for us on Thursday April 20th, as the stock was mentioned in the room and subsequently went on a big run from .0005-.0017 (+240%).

We brought it up in our premarket report the following day, and the run continued from .0016-.0029 (+81%). After that a slight pullback occurred over the next session, but since then the stock has been on the rise again, and this week has brought new highs.

Yesterday, after appearing in our morning report once again, BLDV went on another tear and reached a new high for us. The stock made a 42% intraday push from .0036 and hit .0051. From our observed low of just nine sessions earlier, the stock has increased by an incredible 920%

Even those who missed the initial chatroom call and only caught BLDV in our premarket report on Friday the 21st at its low of .0016 that day, still had a chance at up to 219% in gains. The stock had a pretty strong close on high volume, so we’ll continue to monitor its progress even though it has already served us so well.

*Finding opportunities in the premarket is a big part of what we do every single trading day, but sometimes the real movers don’t reveal themselves until regular market hours commence. That’s where the chatroom comes in, giving ourselves and our participants the chance to spot and share the big movers as they crop up. Send a Skype contact request to ‘stocksumo‘ to get involved with our trader’s chats!



Balmoral Resources, Ltd. BALMF

After noticing the company released what it referred to as “high grade gold results from its Detour Gold Trend Project in Quebec” in a fresh PR this morning (>>View PR) we also took a look at the BALMF chart and saw that the stock itself has been working its way down to a bottom recently and is approaching heavily oversold territory.

Indications are that it could see slightly lower prices before making a rebound, so we’ll just want to ensure that it holds at or above December’s swing low of .46 on any further pullbacks. If it does, we’ll be very interested to track BALMF, especially given the fact that they’re officially ‘on the gold’ at their Quebec property.


Weight Watchers International, Inc. WTW – Options Idea

Weight Watchers has been breaking into blue skies, with an incredible bullish move that has lasted for the better part of six weeks. Heavy activity in this morning’s premarket leads us to think that despite already being up so high, WTW’s good fortunes could continues for awhile longer.

We’ll have an eye on the WTW Weekly $24-25 Calls on the chance that our hunch in correct.


Extended Watchlist:
PHMD, BLRX, PIRS, ESES, APOP

Blue Horseshoe Stocks: Options Update & Much More

Amedica Corp. AMDA

After providing us with the chance for intraweek gains of 61% last week, as we were mentioning in yesterday’s morning report, AMDA turned in another healthy performance for the day.

From a morning low of .58, the stock pressed to a new high of .70; a 21% intraday move, and this morning the stock is gapping up once again. As of this morning’s premarket high, the total range we’ve now observed in AMDA in just a week’s time stands at 102% from last Tuesday’s low of .3851.

Yesterday’s solid showing also marked the fifth consecutive trading day that AMDA managed to register higher lows and higher highs. We’ll continue to track its activity as the week progresses. A dip-and-rip off of this morning’s new high is a distinct possibility.


Under Armour, Inc. UA – Options Update

UA was a point of focus for us on Friday morning, at which time we submitted a medium-term options idea for the stock, namely the 07/31 $84 Calls. We wanted to provide an update on the subsequent performance of those contracts, which managed a notable increase between Friday and yesterday.

From a low of 2.76, the July $84’s have traded as high as 3.53 thus far. That hashes out to total possible gains of 28% over just a couple of trading sessions. With plenty of time left until expiration, we’ll be sure to keep a slot reserved for those contracts from this point forward.


TapImmune, Inc. TPIV

We’ve been tracking TPIV for nearly two weeks now. We tagged it for the first time on June 10th, and we slipped a reminder into Friday’s report as well.

We certainly hope those alerts caught someone’s attention, because TPIV has certainly caught ours; yesterday’s high of 1.23 represented a 28% jump from the low following Friday’s alert (.962) and an overall increase of 71% from the low following our initial alert (.72).


Sipp Industries, Inc. SIPC

SIPC is catching our attention this morning after announcing the addition of “Hemp co-packing, storage, distribution, and private label solutions to product offering.” in an early PR. It caused us to take notice of the chart, which is currently boasting an attractive setup with regard to its potential as a bottom-play. We’re going to keep a close eye on SIPC as we head into mid-week.


Extended Watchlist:
PHMD, BIND, NSPR, TBIO, BBRY

Blue Horseshoe Stocks: Pharma Watchlist & More

Lexicon Pharmaceuticals, Inc. LXRX

We’re taking notice of LXRX this morning in the wake of a premarket PR that has the stock trending up to its highest levels of the past three months; it contained updates on current projects as well as increased earnings. The addition of an interesting setup on the chart gives us good reason to place LXRX on watch this mid-week.

As you can see on the snapshot below, the stock gapped down significantly at the end of November. In premarket activity today we’re seeing a partial fill taking place. We’re going to be watching for LXRX to fill the remainder of the gap into the mid 1.20’s where its next area of resistance will come in at the 200DMA of 1.28.

THE WOODLANDS, Texas, March 4, 2015 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.>> VIEW PR


Pharmaceutical Watchlist

There are a number of other pharma and biopharma stocks gapping up in the premarket this morning, some of which have appeared in our reports in the past. We’ve listed them below along with links to today’s news, where applicable:

Keryx Biopharmaceuticals, Inc. KERX


Atossa Genetics, Inc. ATOS


Coronado Biosciences, Inc. CNDO

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies (Wed 8:30AM EST)

PhotoMedex, Inc. PHMD

Orexigen Therapeutics, Inc. OREX

KaloBios Pharmaceuticals, Inc. KBIO


Earnings-Related Options Ideas

American Eagle Outfitters, Inc. AEO beat expected Q4 profits and revenues, and is gapping up as a result. To take advantage of the trend, we are monitoring options trading possibilities in the AEO Weekly $15-16 Calls

Abercrombie & Fitch ANF fell short of expectations with regard to sales, which is fueling a downtrend here in the premarket, so we’ll take the opposite approach here, and keep an eye on ANF Weekly $23-24 Puts.


Extended Watchlist:
IFON, PLUG, NPTN, WLT, LEI